BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17088047)

  • 1. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.
    Mak A; Liu Y; Ho RC
    J Rheumatol; 2011 Jul; 38(7):1296-303. PubMed ID: 21459950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF; Lieps D; Schatz H; Pfohl M
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.
    Fadini GP; Pagano C; Baesso I; Kotsafti O; Doro D; de Kreutzenberg SV; Avogaro A; Agostini C; Dorigo MT
    Acta Ophthalmol; 2010 Feb; 88(1):135-41. PubMed ID: 19549102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of shear stimulus, risk factor burden and early atherosclerosis on the time-course of brachial artery flow-mediated vasodilation.
    Chironi G; Craiem D; Miranda-Lacet J; Levenson J; Simon A
    J Hypertens; 2008 Mar; 26(3):508-15. PubMed ID: 18300862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial dysfunction and early atherosclerosis in non-differentiated collagenosis].
    Kerekes G; Bodolay E; Sipka S; Szomják E; Veres K; Zeher M; Szegedi G; Soltész P
    Orv Hetil; 2005 Apr; 146(17):791-5. PubMed ID: 17918635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired flow-mediated endothelium-dependent and endothelium-independent vasodilation of the brachial artery in patients with atherosclerotic peripheral vascular disease.
    Komai H; Higami Y; Tanaka H; Honda K; Juri M; Okamura Y
    Angiology; 2008; 59(1):52-6. PubMed ID: 18319222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.
    Ferreira GA; Navarro TP; Telles RW; Andrade LE; Sato EI
    Rheumatology (Oxford); 2007 Oct; 46(10):1560-5. PubMed ID: 17693444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.